Adenine Market in China
In China, following a mild (-2.4%) contraction in 2020, adenine market in terms of volume rose dramatically (9.5%), reaching 1,991 tons in 2021, according to StrategyHelix’ study.
In China, following a mild (-2.4%) contraction in 2020, adenine market in terms of volume rose dramatically (9.5%), reaching 1,991 tons in 2021, according to StrategyHelix’ study.
According to StrategyHelix, the high-value ophthalmic consumables market in China is expected to increase by US$ 2,246 million during 2021-2027, expanding at a CAGR of 14.5% during the forecast period.
According to StrategyHelix, the ophthalmic drugs market in China is expected to increase by US$ 2,245 million during 2021-2027, expanding at a CAGR of 8.7% during the forecast period.
A statistic by StrategyHelix indicates that the joint replacement surgical robots market in China is set to grow at a healthy compound annual growth rate (CAGR) of 45.4% in the next five years.
A statistic by StrategyHelix indicates that the joint replacement surgical robots market in USA is expected to increase by US$ 1,170 million from 2021 to 2027, garnering a CAGR of 17.5% during the forecast period.
A statistic by StrategyHelix indicates that the laparoscopic surgical robot market in China is expected to increase by US$ 2,200 million from 2021 to 2027, garnering a CAGR of 31.1% during the forecast period.
A statistic by StrategyHelix indicates that the laparoscopic surgical robot market in USA is expected to increase by US$ 3,801 million from 2021 to 2027, garnering a CAGR of 13.6% during the forecast period.
The surgical robot market in China is poised to grow by US$ 3,774 million during 2021-2027, progressing at a CAGR of 35.2% during the forecast period, according to data and analytics company StrategyHelix.
The global surgical robot market is poised to grow at a CAGR of around 22.3% over the analysis period of 2021 to 2027, according to StrategyHelix.
According to StrategyHelix, the adult incontinence products market in China is expected to increase by US$ 1,188 million during 2021-2027, expanding at a CAGR of 12.1% during the forecast period.
Copyright © 2022 StrategyHelix Inc. All Rights Reserved.